Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
|ClinicalTrials.gov Identifier: NCT00664755|
Recruitment Status : Unknown
Verified July 2010 by Medical University of South Carolina.
Recruitment status was: Recruiting
First Posted : April 23, 2008
Last Update Posted : August 5, 2011
|Condition or disease||Intervention/treatment||Phase|
|Nicotine Dependence||Drug: varenicline Device: transdermal nicotine patch||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||214 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity|
|Study Start Date :||July 2007|
|Estimated Primary Completion Date :||July 2012|
|Estimated Study Completion Date :||July 2012|
Participant randomized to receive active varenicline and placebo transdermal nicotine patch.
Day -7 thru -5: 0.5mg QD Day -4 thru -1: 0.5mg BID Day 0 onward: 1.0mg BID
Varenicline is taken for a duration of 4 weeks in this study.
Other Name: Chantix
Active Comparator: 2
Participant randomized to receive active transdermal nicotine patch and placebo varenicline.
Device: transdermal nicotine patch
Weeks 0-3: 21mg patch
Transdermal nicotine patch is used for a duration of 3 weeks in this study.
Other Name: Nicoderm CQ
- Time to relapse. [ Time Frame: 7 days ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00664755
|Contact: Ashley McCullough, MSW||(843) email@example.com|
|Contact: Jessica H. Olsen, BS||(843) firstname.lastname@example.org|
|United States, South Carolina|
|Medical University of South Carolina||Recruiting|
|Charleston, South Carolina, United States, 29425|
|Contact: Ashley McCullough, MSW 843-792-5842 email@example.com|
|Contact: Jessica H. Olsen, BS (843) 792-4009 firstname.lastname@example.org|
|Principal Investigator: Kevin Gray, MD|
|Principal Investigator: Michael Saladin, PhD|
|Principal Investigator:||Kevin Gray, MD||Medical University of South Carolina|
|Principal Investigator:||Michael E Saladin, PhD||Medical University of South Carolina|